ATE293439T1 - Verfahren und system zur gleichmä igen arzneistoffabgabe - Google Patents

Verfahren und system zur gleichmä igen arzneistoffabgabe

Info

Publication number
ATE293439T1
ATE293439T1 AT01128075T AT01128075T ATE293439T1 AT E293439 T1 ATE293439 T1 AT E293439T1 AT 01128075 T AT01128075 T AT 01128075T AT 01128075 T AT01128075 T AT 01128075T AT E293439 T1 ATE293439 T1 AT E293439T1
Authority
AT
Austria
Prior art keywords
agent
core
release
drugs
even delivery
Prior art date
Application number
AT01128075T
Other languages
English (en)
Inventor
Mebrahtu Fessehaie
Isaac Ghebre-Sellassie
Matthew Joseph Mollan Jr
Monzer Michael Mayassi
Haimanot Woldegaber
Stephen Craig Dyar
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22954223&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE293439(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Application granted granted Critical
Publication of ATE293439T1 publication Critical patent/ATE293439T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0092—Hollow drug-filled fibres, tubes of the core-shell type, coated fibres, coated rods, microtubules or nanotubes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nanotechnology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT01128075T 2000-12-07 2001-11-27 Verfahren und system zur gleichmä igen arzneistoffabgabe ATE293439T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US25199600P 2000-12-07 2000-12-07

Publications (1)

Publication Number Publication Date
ATE293439T1 true ATE293439T1 (de) 2005-05-15

Family

ID=22954223

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01128075T ATE293439T1 (de) 2000-12-07 2001-11-27 Verfahren und system zur gleichmä igen arzneistoffabgabe

Country Status (9)

Country Link
US (1) US20020119197A1 (de)
EP (1) EP1213014B1 (de)
JP (1) JP2002212061A (de)
AT (1) ATE293439T1 (de)
BR (1) BR0105909A (de)
CA (1) CA2363902C (de)
DE (1) DE60110192T2 (de)
ES (1) ES2240313T3 (de)
MX (1) MXPA01012456A (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6217895B1 (en) * 1999-03-22 2001-04-17 Control Delivery Systems Method for treating and/or preventing retinal diseases with sustained release corticosteroids
US6375972B1 (en) 2000-04-26 2002-04-23 Control Delivery Systems, Inc. Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
US20040234602A1 (en) 2001-09-21 2004-11-25 Gina Fischer Polymer release system
WO2003024430A1 (en) 2001-09-21 2003-03-27 Egalet A/S Morphine polymer release system
KR20100120243A (ko) * 2002-05-07 2010-11-12 피시비다 유에스 인코포레이티드 약물 전달 장치를 형성하는 공정
US8871241B2 (en) * 2002-05-07 2014-10-28 Psivida Us, Inc. Injectable sustained release delivery devices
ES2360102T3 (es) 2003-03-26 2011-05-31 Egalet A/S Sistema para la liberación controlada de morfina.
AU2004232370B2 (en) * 2003-04-21 2009-12-10 Euro-Celtique S.A. Tamper resistant dosage form comprising co-extruded, adverse agent particles and process of making same
DE602004005076T2 (de) * 2003-12-09 2007-11-15 Euro-Celtique S.A. Co-extrudierte sicherheits-dosierform mit einem wirkstoff und einem adversen mittel und herstellungsverfahren dafür
AT500144A1 (de) * 2004-03-05 2005-11-15 Sanochemia Pharmazeutika Ag Tolperison enthaltende, pharmazeutische zubereitung mit steuerbarer wirkstofffreisetzung zur oralen verabreichung
AU2005231146B2 (en) * 2004-03-30 2008-12-11 Euro-Celtique S.A. Tamper resistant dosage form comprising an adsorbent and an adverse agent
US20090088465A1 (en) * 2004-12-02 2009-04-02 Stephen Craig Dyar Pharmaceutical Compositions of Amorphous Atorvastatin and Process for Preparing Same
WO2008004127A2 (en) * 2006-04-20 2008-01-10 Sanochemia Pharmazeutika Ag Method for administering tolperisone
EP1859788A1 (de) * 2006-05-24 2007-11-28 Abbott GmbH & Co. KG Herstellung von umhüllten pharmazeutischen Darreichungsformen
DE102006033723A1 (de) * 2006-07-21 2008-01-24 Bayer Technology Services Gmbh Formulierungen von Multikompartimenten-Granulaten für Wirkstoffe
WO2008148798A2 (en) 2007-06-04 2008-12-11 Egalet A/S Controlled release pharmaceutical compositions for prolonged effect
US8318257B2 (en) * 2007-09-28 2012-11-27 Dow Global Technologies Llc Dispersions of higher crystallinity olefins
DK2393487T3 (en) 2009-02-06 2017-01-23 Egalet Ltd Pharmaceutical compositions resistant to abuse
NZ594207A (en) 2009-02-06 2013-03-28 Egalet Ltd Immediate release composition resistant to abuse by intake of alcohol
AU2010265213B2 (en) 2009-06-24 2012-08-23 Egalet Ltd. Controlled release formulations
EP2544667B1 (de) * 2010-03-09 2018-11-14 Alkermes Pharma Ireland Limited Alkoholresistente enterale pharmazeutische zusammensetzungen
CA2807319C (en) * 2010-08-18 2018-08-14 Mcneil-Ppc, Inc. Tablet sleeve for improved performance
US9233076B2 (en) 2010-12-13 2016-01-12 Purdue Pharma L.P. Controlled release dosage forms
BR112015000150A2 (pt) 2012-07-06 2017-06-27 Egalet Ltd composições farmacêuticas dissuasoras de abuso de liberação controlada
WO2015184407A1 (en) * 2014-05-30 2015-12-03 Textile-Based Delivery, Inc. Drug delivery systems and related methods of use
MX2017005399A (es) 2014-10-30 2017-07-26 Textile-Based Delivery Inc Sistemas de administracion.
AU2017300185B2 (en) 2016-07-17 2023-02-02 Mapi Pharma Ltd. Extended release dosage forms of pregabalin
CN113456626B (zh) * 2021-08-16 2022-05-06 吉林大学 一种黄嘌呤氧化酶抑制剂及其筛选方法和应用
CN115300475B (zh) * 2022-07-20 2024-10-22 九华华源药业(桂林)有限公司 苯溴马隆渗透泵控释片及其制备方法与应用
WO2026022379A1 (en) 2024-07-26 2026-01-29 Inkvivo Technologies Sa Gastroretentive formulations

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0406315B1 (de) * 1988-03-24 1992-11-11 Bukh Meditec A/S Geregelte verabreichungszusammensetzung
DK469989D0 (da) * 1989-09-22 1989-09-22 Bukh Meditec Farmaceutisk praeparat
ATE125699T1 (de) * 1990-10-01 1995-08-15 Upjohn Co Arzneimittel zur gesteuerten freisetzung mit einer überzogenen seitlichen randfläche.
US6787156B1 (en) * 1994-02-23 2004-09-07 Bm Research A/S Controlled release composition
FR2766088B1 (fr) * 1997-07-17 2001-01-05 Dow Corning Sa Dispositifs a liberation controlee d'un agent pharmaceutique, leur fabrication par co-extrusion et article intermediaire
HN1998000115A (es) * 1997-08-21 1999-06-02 Warner Lambert Co Formas de dosificación farmacéuticas sólidas

Also Published As

Publication number Publication date
ES2240313T3 (es) 2005-10-16
DE60110192D1 (de) 2005-05-25
DE60110192T2 (de) 2006-03-09
MXPA01012456A (es) 2005-06-30
EP1213014A3 (de) 2002-07-03
JP2002212061A (ja) 2002-07-31
CA2363902A1 (en) 2002-06-07
BR0105909A (pt) 2002-08-13
US20020119197A1 (en) 2002-08-29
EP1213014B1 (de) 2005-04-20
CA2363902C (en) 2005-07-26
EP1213014A2 (de) 2002-06-12

Similar Documents

Publication Publication Date Title
ATE293439T1 (de) Verfahren und system zur gleichmä igen arzneistoffabgabe
ATE366104T1 (de) Verfahren zur herstellung von in der mundhöhle rasch zerfallenden tabletten
ATE314075T1 (de) Verfahren zur herstellung diphosphonsäure enthaltende feste pharmazeutische darreichungsformen
DE59104172D1 (de) Verfahren zur herstellung wirkstoffhaltiger mikropartikel aus hydrolytisch abbaubaren polymeren.
DE60329298D1 (de) Polymerisierbare zusammensetzung, die zusammensetzung enthaltendes optisches material und verfahren zur herstellung des materials
CY1107512T1 (el) Νεες υποκατεστημενες με βενζιμιδαζολιο μορφες δοσολογιας και μεθοδος για τη χρηση τους
FR2679450B1 (fr) Procede pour la preparation de microspheres en matiere polymere biodegradable, pour la liberation controlee de substances medicamenteuses peptidiques.
DE69935330D1 (de) Neue acylierte pseudodipeptide, verfahren zu ihrer herstellung, und diese enthaltende pharmazeutische zusammensetzungen
ATE409023T1 (de) Wirkstoffverabreichungssysteme mit verzögerter freisetzung, verwendung und verfahren zur herstellung derselben
ATE243193T1 (de) Benzocycloheptene, verfahren zu ihrer herstellung,pharmazeutische präparate die diese enthalten sowie deren verwendung zur herstellung von arzneimitteln
DE122010000051I1 (de) Verfahren zur herstellung oberflachenmodifizierternanoskaliger keramischer pulver.
NO960067D0 (no) Nytt farmasöytisk preparat
DE69636783D1 (de) Verfahren und pharmazeutische zusammensetzung zur regelung der lipidkonzentration
DE69625923D1 (de) Oxidmaterialien, verfahren zur dessen herstellung und diese materialien enthaltende katalysatorzusammensetzungen
DE3880762D1 (de) Orale, acetaminophen enthaltende zusammensetzung mit gesteuerter arzneistoff-freisetzung und verfahren zu ihrer herstellung.
DE69723571D1 (de) Methyliden-malonat nanopartikel, verfahren zu deren herstellung, und diese enthaltende pharmazeutische praeparate
DE59908764D1 (de) Agitationsunabhängige pharmazeutische multiple-unit-retardzubereitungen und verfahren zu ihrer herstellung
ATE442852T1 (de) Trimetazidine enthaltendes arzneimittel mit verzögerter wirkstoffabgabe und verfahren zur herstellung
DE59608606D1 (de) Cyclosprorin(e) enthaltende pharmazeutische zubereitung zur oralen applikation und verfahren zu ihrer herstellung
DE69617435D1 (de) Absorbierendes material, formkörper aus diesem material und verfahren zur herstellung des materials.
DK1267833T3 (da) Farmaceutiske præparater og fremgangsmåde til fremstilling deraf
DE69103922D1 (de) Verfahren zur Herstellung arzneistoffhaltiger Tabletten mit verzögerter Freigabe.
IT1267827B1 (it) Dispositivo manipolatore automatico, particolarmente per lastre di marmo, granito ed altri materiali lapidei.
DE68905837D1 (de) 2-(alkyl-cyclohexyl)-1-propanol, verfahren zu dessen herstellung und ihn enthaltende riechstoffzusammensetzung.
EA200501221A1 (ru) Фармацевтическая композиция алендроновой кислоты, ее солей или сложных эфиров и способ ее получения

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties